Regeneron Pharmaceuticals Inc is a biotech firm based in Tarrytown, New York, known for its innovative approach to developing and commercializing medicines for a variety of diseases. The company's portfolio includes treatments for eye conditions like wet age-related macular degeneration, skin diseases such as atopic dermatitis, and other serious ailments including asthma, cardiovascular disease, and certain cancers. Regeneron is also notable for its contributions to infectious disease treatments, including a therapy for COVID-19 and the Ebola virus. Founded in 1988, Regeneron stands out for its commitment to addressing unmet medical needs.
FDA calendars are stacking up fast, obesity Phase 3 data is closing in, and three biotech names spanning the risk spectrum are quietly positioning for a pivotal back half of 2026.
On CNBC’s Mad Dash segment on Monday, July 6, 2026, Jim Cramer made one of his most bullish biotech calls in years, arguing that the sector could be entering a new wave…
If you’re looking to diversify outside of AI, especially as AI investors look to trim their winners to save up for that mega-cap AI IPO boom on the horizon, with SpaceX leading…
Pre-Market Stock Futures: Futures are trading lower after a spectacular week came to an abrupt end Friday, as all the major indices were absolutely hammered. Voices across financial media were busy pointing out…
Kymera Therapeutics (NASDAQ:KYMR) CEO Nello Mainolfi had one line on the February 26, 2026 earnings call that deserves attention beyond the headline numbers: his company just put the first IRF5-directed therapy in…
Pre-Market Stock Futures: Futures are trading lower as we prepare to finally end what has been one of the most volatile weeks in recent memory, with oil hitting its highest level since…
Most ETF names tell you what they own. COWG tells you what it believes in. Pacer US Large Cap Cash Cows Growth Leaders ETF (NYSEARCA:COWG) screens for large-cap US companies generating strong…
Pre-Market Stock Futures: Futures are trading lower on Wednesday after an ADP report showing job losses, following a stellar day across Wall Street on Tuesday. All of the major indices finished the…
Prognostications that the AI bubble is grossly overbought have been increasing. The fact that the Magnificent 7 AI stocks, such as Microsoft (NASDAQ: MSFT | MSFT Price Prediction), Apple (NASDAQ: AAPL), Nvidia…
I’m a massive fan of Dr. Michael Burry, the man played by Christian Bale in The Big Short, not only because he’s made some incredible (albeit high-stakes) calls, even in the years…
Markets are tanking on tariff fears, inflationary concerns and now fears of recession. “Given this is so uncertain and that there are new announcements every hour or so, it’s kind of unclear…
Pharma stocks have been on quite a nice run over the past year. A number of new catalysts have revitalized this sector, which I’m going to dive into with a few of…
Thursday's top analyst upgrades and downgrades included DocuSign, Etsy, Guardant Health, International Paper, Johnson Controls, Kosmos Energy, Levi Strauss, Snowflake, Tesla, Topgolf Calloway Brands, WW International and XPO.
Tuesday's top analyst upgrades and downgrades included Academy Sports and Outdoors, Boston Scientific, Ciena, CrowdStrike, Emerson Electric, Kimco Realty, Nike, NovoCure and Zimmer Biomet.
Thursday's top analyst upgrades and downgrades included Brixmor Property, CAVA, Chevron, GE Healthcare Technologies, Keurig Dr Pepper, News Corp, PACCAR, Permian Resources, Pioneer Natural Resources, Sea and Visa.
